Invesco Nasdaq Biotechnology ETF (IBBQ) is an ETF managed by Invesco. Its largest position is APPLIED MATERIALS INC /DE (AMAT), representing 14.29% of fund assets.
Invesco Nasdaq Biotechnology ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- IBBQ
- Type:
- ETF
- Manager:
- Invesco
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
APPLIED MATERIALS INC /DE
|
14.29% | $10,825,716.74 | 10,825,717 |
|
-
GILEAD SCIENCES, INC.
|
9.61% | $7,278,441.75 | 48,865 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
9.30% | $7,044,055.74 | 14,178 |
|
-
AMGEN INC
|
9.12% | $6,907,695.36 | 17,796 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
6.03% | $4,564,171.13 | 5,839 |
|
-
APPLIED MATERIALS INC /DE
|
5.55% | $4,201,476.69 | 4,201,477 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
3.28% | $2,486,912.40 | 7,470 |
|
-
INSMED Inc
|
2.38% | $1,801,666.45 | 12,065 |
|
-
BIOGEN INC.
|
2.10% | $1,591,146.90 | 8,295 |
|
-
ARGENX SE
|
1.67% | $1,263,884.16 | 1,648 |
|
-
UNITED THERAPEUTICS Corp
|
1.62% | $1,228,004.30 | 2,437 |
|
-
Moderna, Inc.
|
1.56% | $1,184,379.13 | 22,109 |
|
-
ILLUMINA, INC.
|
1.53% | $1,162,541.16 | 8,646 |
|
-
Roivant Sciences Ltd.
|
1.50% | $1,139,338.86 | 39,369 |
|
-
INCYTE CORP
|
1.49% | $1,125,616.05 | 11,115 |
|
-
Royalty Pharma plc
|
1.47% | $1,116,941.91 | 24,171 |
|
-
Revolution Medicines, Inc.
|
1.47% | $1,115,894.76 | 10,938 |
|
-
Viatris Inc
|
1.28% | $973,107.54 | 65,178 |
|
-
Ascendis Pharma A/S
|
1.07% | $811,179.00 | 3,474 |
|
-
NEUROCRINE BIOSCIENCES INC
|
0.98% | $746,022.25 | 5,641 |
|
-
IONIS PHARMACEUTICALS INC
|
0.98% | $743,577.45 | 9,163 |
|
-
Sanofi
|
0.96% | $729,316.08 | 14,988 |
|
-
BridgeBio Pharma, Inc.
|
0.96% | $725,828.64 | 10,918 |
|
-
Medpace Holdings, Inc.
|
0.95% | $719,653.68 | 1,593 |
|
-
Summit Therapeutics Inc.
|
0.92% | $699,666.66 | 42,174 |
|
-
Guardant Health, Inc.
|
0.91% | $687,254.10 | 7,319 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
0.89% | $671,931.05 | 10,885 |
|
-
EXELIXIS, INC.
|
0.88% | $668,610.50 | 15,175 |
|
-
Jazz Pharmaceuticals plc
|
0.86% | $654,048.84 | 3,442 |
|
-
BioNTech SE
|
0.83% | $631,176.98 | 5,726 |
|
-
BeOne Medicines Ltd.
|
0.75% | $565,510.16 | 1,784 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
0.73% | $555,984.00 | 1,287 |
|
-
ImmunityBio, Inc.
|
0.72% | $546,516.18 | 55,881 |
|
-
Tempus AI, Inc.
|
0.69% | $522,329.25 | 9,809 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
0.64% | $485,660.52 | 7,676 |
|
-
Praxis Precision Medicines, Inc.
|
0.63% | $478,185.00 | 1,420 |
|
-
Axsome Therapeutics, Inc.
|
0.62% | $466,922.61 | 2,849 |
|
-
HALOZYME THERAPEUTICS, INC.
|
0.61% | $463,834.63 | 6,671 |
|
-
Vaxcyte, Inc.
|
0.61% | $458,419.50 | 7,425 |
|
-
Krystal Biotech, Inc.
|
0.60% | $453,703.44 | 1,646 |
|
-
CYTOKINETICS INC
|
0.57% | $428,322.48 | 6,884 |
|
-
NUVALENT INC-A
|
0.55% | $418,096.95 | 4,101 |
|
-
Abivax S.A.
|
0.53% | $404,711.36 | 3,337 |
|
-
ARCELLX INC
|
0.49% | $372,776.04 | 3,276 |
|
-
Kymera Therapeutics, Inc.
|
0.49% | $371,520.45 | 4,067 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
0.46% | $349,963.02 | 3,774 |
|
-
Cogent Biosciences, Inc.
|
0.45% | $339,471.30 | 8,738 |
|
-
Protagonist Therapeutics, Inc
|
0.43% | $327,804.80 | 3,560 |
|
-
CRISPR Therapeutics AG
|
0.43% | $325,778.38 | 5,417 |
|
-
Caris Life Sciences, Inc.
|
0.42% | $319,319.70 | 15,855 |
Advertisement (320x50)